contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment CompanyTagList on Company {
  pageUrl
  name
  viewerIsFollowing
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    ...CompanyTagList
    id
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls {
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      defaultInstrument {
        isin
        id
      }
      id
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    id
    name
    viewerIsFollowing
    defaultInstrument {
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


new-nordic-healthbrands-ab-publ-part-ways-with-chief-commercial-and-operating-officer

__typename

title

isPremium

lang

htmlBody

companies

createdAt

publishers

authors

reactionGroups

pageUrl

alternatePageUrls

imgUrl

description

New Nordic Healthbrands är specialiserat mot att utveckla och marknadsföra kosttillskott och naturläkemedel. Största delen av sortimentet utgörs av hälsofrämjande örter. Produkterna säljs via bolagets återförsäljare och tillskotten används exempelvis inom hud- och hårvård, för förbättring av immunsystemet och synförmågan, samt som generella vitamintillskott. Huvudkontoret ligger i Malmö.

New Nordic Healthbrands

We have today decided to part ways with Chief Commercial and Operating Officer Mr. Tage Juhl Finninge. Tage and CEO Karl Kristian Bergman Jensen both had faith in being able to develop New Nordic...

<div class="bequoted-body"><p>We have today decided to part ways with Chief Commercial and Operating Officer Mr. Tage Juhl Finninge. Tage and CEO Karl Kristian Bergman Jensen both had faith in being able to develop New Nordic together. Unfortunately, the collaboration showed over time that Tage and Karl Kristian's approach to business are too different for an effective teamwork and decision-making and therefore the collaboration had to end.</p><p>As of today, CFO, Ivan Ruscic and Karl Kristian will form the Executive Management Team at NEW NORDIC.</p><p>We will not search for another CCO or COO in the near future.</p><p>Karl Kristian Bergman Jensen, CEO<br>New Nordic Healthbrands AB</p><p>Malmö 29 September 2023</p></div><div class="bequoted-contact"><p>Link to New Nordic's investor relation web page: https://newnordicinvestor.com&nbsp;</p><p><strong>Contact:</strong></p><p>Karl Kristian Bergman Jensen, CEO, telephone +46 40-236414, e-mail <a rel="noopener" href="mailto:kk@newnordic.com">kk@newnordic.com</a>.<br>Ivan Ruscic, CFO, telephone +46 40-236414, e-mail <a rel="noopener" href="mailto:ivan@newnordic.se">ivan@newnordic.se</a><br>Claes Libell, Group Financial Controller and Investor Relations, telephone +46 40-236414, e-mail <a rel="noopener" href="mailto:claes@newnoridc.se">claes@newnordic.se</a>&nbsp;</p><p>New Nordic Healthbrands AB (publ), SE-215 32&nbsp; Malmö, Sweden. Org. nr. 556698-0453.</p><p>Certified advisor: Mangold Fondkommission AB. +46 8 503 01 550, <a rel="noopener" href="mailto:ca@mangold.se">ca@mangold.se</a>&nbsp;</p></div><div class="bequoted-about"><p>New Nordic Healthbrands AB (publ) was founded in 1990 and is listed on Nasdaq First North Growth Market Sweden since 2007. The company's business concept is to offer the most effective and safe dietary supplements, natural medicines and cosmetic products for specific health and beauty needs. All with care for people and nature. New Nordic products are now available in 41 countries in pharmacies, health stores, beauty shops, and travel retail. New Nordic has its own small sales and marketing companies in most European countries, Canada and the United States, Hong Kong and Australia, to organise local marketing campaigns, serve retailers and serve end customers. In 2022, revenues were SEK 488 million. Almost all New Nordic products sold worldwide are manufactured in Scandinavia. For more information, visit <a rel="noopener" href="http://www.newnordic.com">www.newnordic.com</a>&nbsp;</p></div><div class="bequoted-files"><p><strong>Attached files</strong></p><a href="https://cdn.bequoted.com/media/1/9bf27a25-99b2-4d8e-8e4b-a0d63a0e94bf/New_Nordic_Pressrelease_2023-09-29.pdf">New_Nordic_Pressrelease_2023-09-29.pdf</a><br></div>

New Nordic Healthbrands AB (publ) part ways with Chief Commercial and Operating Officer

Return on capital (ROE, ROI, ROIC, RONIC)

What does negative working capital mean and why is it a good thing?

Drug development investment: Value creation through M&As and licensing agreements

Income statement

Amazon continues to grow in Sweden

Beställ vårt nyhetsbrev — inget användarkonto krävs!